Peio Errarte

595 total citations
21 papers, 470 citations indexed

About

Peio Errarte is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peio Errarte has authored 21 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Peio Errarte's work include Peptidase Inhibition and Analysis (12 papers), Renal cell carcinoma treatment (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Peio Errarte is often cited by papers focused on Peptidase Inhibition and Analysis (12 papers), Renal cell carcinoma treatment (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Peio Errarte collaborates with scholars based in Spain, Norway and United Kingdom. Peio Errarte's co-authors include Gorka Larrinaga, José I. López, Maider Beitia, J.C. Angulo, Rafael Pulido, Carmen Etxezarraga, Itxaro Pérez, Lorena Blanco, Begoña Sanz and Caroline E. Nunes‐Xavier and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

In The Last Decade

Peio Errarte

21 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peio Errarte Spain 12 289 173 147 127 84 21 470
Joëlle Siat France 9 166 0.6× 188 1.1× 278 1.9× 94 0.7× 126 1.5× 27 564
Rong‐Liang Shi China 15 142 0.5× 138 0.8× 95 0.6× 72 0.6× 73 0.9× 28 431
Carsten Haeckel Germany 14 154 0.5× 168 1.0× 133 0.9× 131 1.0× 60 0.7× 20 446
Jinchun Yan United States 13 211 0.7× 466 2.7× 165 1.1× 324 2.6× 55 0.7× 26 807
Masahiko Zuka Japan 7 151 0.5× 160 0.9× 47 0.3× 49 0.4× 73 0.9× 15 440
Ye Xu China 12 252 0.9× 270 1.6× 81 0.6× 199 1.6× 122 1.5× 22 589
Masayuki Komatsu Japan 9 112 0.4× 162 0.9× 107 0.7× 79 0.6× 68 0.8× 19 339
Lenka Krsková Czechia 12 128 0.4× 148 0.9× 128 0.9× 71 0.6× 58 0.7× 55 455
Ayse Ceren Mutgan Germany 7 131 0.5× 152 0.9× 110 0.7× 94 0.7× 31 0.4× 12 348
Anita Rodenas France 8 199 0.7× 63 0.4× 126 0.9× 72 0.6× 50 0.6× 12 387

Countries citing papers authored by Peio Errarte

Since Specialization
Citations

This map shows the geographic impact of Peio Errarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peio Errarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peio Errarte more than expected).

Fields of papers citing papers by Peio Errarte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peio Errarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peio Errarte. The network helps show where Peio Errarte may publish in the future.

Co-authorship network of co-authors of Peio Errarte

This figure shows the co-authorship network connecting the top 25 collaborators of Peio Errarte. A scholar is included among the top collaborators of Peio Errarte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peio Errarte. Peio Errarte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Øyjord, Tove, Gunhild M. Mælandsmo, J.C. Angulo, et al.. (2024). Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma. OncoImmunology. 13(1). 2419686–2419686. 3 indexed citations
2.
Nunes‐Xavier, Caroline E., Tove Øyjord, Gunhild M. Mælandsmo, et al.. (2023). The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma. Scientific Reports. 13(1). 7339–7339. 7 indexed citations
3.
Armesto, María, María Arestin, Peio Errarte, et al.. (2021). Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC). Cancers. 13(17). 4401–4401. 8 indexed citations
4.
Nunes‐Xavier, Caroline E., Tove Øyjord, Gorka Larrinaga, et al.. (2021). 76P B7-H3 immune checkpoint protein expression is associated with immune exhaustion, overall survival and metastasis in clear cell renal cell carcinoma. Annals of Oncology. 32. S1368–S1368. 1 indexed citations
5.
Larrinaga, Gorka, Peio Errarte, Miguel Unda, et al.. (2021). Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma. Cancers. 13(4). 667–667. 34 indexed citations
6.
Errarte, Peio, et al.. (2020). Erbb4 Is Required for Cerebellar Development and Malignant Phenotype of Medulloblastoma. Cancers. 12(4). 997–997. 2 indexed citations
7.
Errarte, Peio, Carmen Etxezarraga, Enrique Echevarrı́a, et al.. (2020). Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours. Cancers. 12(11). 3393–3393. 26 indexed citations
8.
Beitia, Maider, Peio Errarte, Carmen Etxezarraga, et al.. (2020). Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases. Aging. 12(11). 10337–10358. 31 indexed citations
10.
Beitia, Maider, Peio Errarte, Begoña Sanz, et al.. (2019). Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence. International Journal of Medical Sciences. 16(6). 813–821. 10 indexed citations
11.
Errarte, Peio, Gorka Larrinaga, & José I. López. (2019). The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions. Journal of Advanced Research. 21. 103–108. 52 indexed citations
12.
Calvete, Juan J., Gorka Larrinaga, Peio Errarte, et al.. (2019). The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder. Human Pathology. 91. 61–68. 50 indexed citations
13.
Errarte, Peio, Maider Beitia, Itxaro Pérez, et al.. (2017). Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients. PLoS ONE. 12(8). e0181711–e0181711. 33 indexed citations
14.
López, José I., Peio Errarte, Asier Erramuzpe, et al.. (2016). Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma. Human Pathology. 54. 100–105. 50 indexed citations
15.
Errarte, Peio, Rosa Guarch, Rafael Pulido, et al.. (2016). The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases. PLoS ONE. 11(12). e0169105–e0169105. 50 indexed citations
16.
Pérez, Itxaro, Lorena Blanco, Begoña Sanz, et al.. (2015). Altered Activity and Expression of Cytosolic Peptidases in Colorectal Cancer. International Journal of Medical Sciences. 12(6). 458–467. 5 indexed citations
17.
Larrinaga, Gorka, Itxaro Pérez, Begoña Sanz, et al.. (2015). Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis. PLoS ONE. 10(3). e0119436–e0119436. 30 indexed citations
18.
Larrinaga, Gorka, Itxaro Pérez, Lorena Blanco, et al.. (2014). Prolyl Endopeptidase Activity Is Correlated with Colorectal Cancer Prognosis. International Journal of Medical Sciences. 11(2). 199–208. 22 indexed citations
19.
Larrinaga, Gorka, Itxaro Pérez, Usue Ariz, et al.. (2013). Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer. Translational research. 162(5). 297–308. 11 indexed citations
20.
Larrinaga, Gorka, Lorena Blanco, Peio Errarte, et al.. (2013). Altered Peptidase Activities in Thyroid Neoplasia and Hyperplasia. Disease Markers. 35(6). 825–832. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026